智通财经APP讯，国药科技股份(08156)公布，预期该集团截至2025年6月30日止年度将取得公司拥有人应占亏损不超过100万港元，同比大幅减少约95%。董事会认为本集团于本报告期内财务表现大幅改善主要归因于(其中包括)以下因素的净影响：(i) 业务改善导致毛利同比增加约920万港元或184%;(ii) 加强行政及营运开支的成本控制;(iii) 本报告期内贷款资本化收益约390万港元;及 (iv) 由于贷款资本化导致本报告期内融资成本减少。
智通财经APP讯，国药科技股份(08156)公布，预期该集团截至2025年6月30日止年度将取得公司拥有人应占亏损不超过100万港元，同比大幅减少约95%。董事会认为本集团于本报告期内财务表现大幅改善主要归因于(其中包括)以下因素的净影响：(i) 业务改善导致毛利同比增加约920万港元或184%;(ii) 加强行政及营运开支的成本控制;(iii) 本报告期内贷款资本化收益约390万港元;及 (iv) 由于贷款资本化导致本报告期内融资成本减少。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.